Skip to main content
OMDA
NASDAQ Industrial Applications And Services

Omada Health Beats Q3, Raises FY26 Revenue and EBITDA Guidance

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$18.95
Mkt Cap
$1.16B
52W Low
$10.28
52W High
$25.54
52W Position info
84% above low
Off High info
26% below high
Rel. Volume info
1.4× avg
Market data snapshot near publication time

OMDA sits 84% above its 52-week low of $10.28.

Summary

Omada Health reported Q3 2026 revenue of $91.3M (+34% YoY), net income of $6.6M and Adjusted EBITDA of $12.4M, then raised full-year revenue and EBITDA guidance.


Key Events · Earnings and Guidance · OMDA

  • Q3 Revenue Up 34% to $91.3M

    Revenue rose to $91.3M from $68.0M in Q3 2025, with Total Members up 36% YoY to 1.1 million and average tenure up 10% to about 2 years and 4 months.

  • First Profitable Quarter at Scale

    Net income was $6.6M versus a $3.2M net loss a year ago; Adjusted EBITDA reached $12.4M from $2.4M, and GAAP gross margin expanded to 76% from 66%.

  • FY26 Guidance Raised on Both Lines

    Revenue outlook lifted to $344M-$346M from $334M-$340M (midpoint ~33% growth), and Adjusted EBITDA to $32M-$34M from $21M-$27M — a midpoint improvement of roughly $27M, about five and a half times 2025.

  • Balance Sheet and Cash Flow

    Cash and cash equivalents stood at $243.2M at September 30, 2026, and free cash flow for the first nine months was $2.5M versus -$7.6M a year earlier.


Analysis · OMDA · Industrial Applications And Services

Omada posted its first clearly profitable quarter at scale: revenue of $91.3M (+34% YoY), net income of $6.6M versus a $3.2M loss a year ago, and Adjusted EBITDA of $12.4M against $2.4M. Gross margin jumped to 76% from 66%, showing the software-like economics of the virtual care model are now showing up in the numbers. Management raised full-year revenue guidance to $344M-$346M from $334M-$340M and, more importantly, lifted Adjusted EBITDA guidance to $32M-$34M from $21M-$27M — the midpoint implies roughly $27M of improvement, about five and a half times 2025. With $243.2M of cash and positive free cash flow of $2.5M for the first nine months, the company no longer needs to lean on external capital. The main caveat is that a previously disclosed material weakness in internal controls remains outstanding, and insiders have been steady sellers under 10b5-1 plans — neither undercuts the operating beat, but both are worth knowing.

How filings like this one have moved

In the 30 days to Nov 5, 2026, 43.4% of the 1274 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.16%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, OMDA was trading at $18.95 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.2B. The 52-week trading range was $10.28 to $25.54. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

OMDA - Latest Insights

OMDA
Sep 10, 2026, 9:02 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $21.84
Real-time Price: $19.99 info
Change: -$1.85 (-8%) info
Market Cap: $1.16B info
OMDA
Sep 09, 2026, 9:01 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $22.18
Real-time Price: $19.99 info
Change: -$2.19 (-10%) info
Market Cap: $1.16B info
OMDA
Aug 07, 2026, 4:13 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $23.67
Real-time Price: $19.99 info
Change: -$3.68 (-16%) info
Market Cap: $1.16B info
OMDA
Jul 08, 2026, 8:17 PM EDT
Filing Type: 4/A
Importance Score:
7
Price at Filing: $23.00
Real-time Price: $19.99 info
Change: -$3.01 (-13%) info
Market Cap: $1.16B info
OMDA
May 08, 2026, 4:12 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $15.75
Real-time Price: $19.99 info
Change: +$4.24 (+27%) info
Market Cap: $1.16B info